Related references
Note: Only part of the references are listed.Spectacular improvement of lung computer tomography after treatment with EGFR tyrosine kinase inhibitor for miliary carcinomatosis
Gabrielle Archer et al.
INTENSIVE CARE MEDICINE (2019)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs)
C. Barth et al.
ANNALS OF INTENSIVE CARE (2018)
Intensive care in thoracic oncology
Anne-Pascale Meert et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Outcomes of cancer therapy administered to treatment-naive lung cancer patients in the intensive care unit
Yen-Fu Chen et al.
JOURNAL OF CANCER (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Treatment of Lung Cancer Patients With Actionable Mutations in the Intensive Care Unit
Kathleen Kerrigan et al.
CLINICAL LUNG CANCER (2016)
Lung cancer at the intensive care unit: The era of targeted therapy
Valerie Adam et al.
LUNG CANCER (2015)
The Lazarus Response in Treatment-Naive, Poor Performance Status Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutation
Corey J. Langer
JOURNAL OF CLINICAL ONCOLOGY (2009)
First-Line Gefitinib for Patients With Advanced Non-Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy
Akira Inoue et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Share Paper
